ECSP003740A - POLYMORPHIC FORM OF A TACHYQUININE RECEPTOR ANTAGONIST - Google Patents
POLYMORPHIC FORM OF A TACHYQUININE RECEPTOR ANTAGONISTInfo
- Publication number
- ECSP003740A ECSP003740A ECSP003740A ECSP003740A EC SP003740 A ECSP003740 A EC SP003740A EC SP003740 A ECSP003740 A EC SP003740A EC SP003740 A ECSP003740 A EC SP003740A
- Authority
- EC
- Ecuador
- Prior art keywords
- methyl
- receptor antagonist
- tachyquinine
- polymorphic form
- triazol
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención tiene que ver con nuevas formas polimórficas del compuesto hidroclorato 2-®-(1-®-(3,5-bis(trifluorometil)-fenil)-etoxi)-4-(5-(dimetil-amino)metil-1,2,3-triazol-4-il)metil-3-(S)-(4-fluorofenil) morfolina, el cual es un antagonista de recptor de taquiquinina útil en el tratamiento o prevención de trastornos del sistema nervioso central, enfermedades inflamatorias, dolor o migraña, asma y emesis. Las presente formas polimórficas, tiene ventajas sobre las otras formas conocidas de hidroclorato 2-(R)-(1-(R)-(3,5-bis(trifluorometil)-fenil)-etoxi)-4-(5-(dimetil-amino)metil-1,2,3-triazol-4-il) metil-3-(S)-(4-fluorofenil)morfolina, en términos de estabilidad termodinámica e idoneidad para su inclusión en formulaciones farmacéuticas.This invention relates to novel polymorphic forms of the hydrochloride compound 2-®- (1-®- (3,5-bis (trifluoromethyl) -phenyl) -ethoxy) -4- (5- (dimethyl-amino) methyl-1 2,3-triazol-4-yl) methyl-3- (S) - (4-fluorophenyl) morpholine, which is a tachykinin receptor antagonist useful in the treatment or prevention of disorders of the central nervous system, inflammatory diseases , pain or migraine, asthma and emesis. The present polymorphic forms have advantages over the other known forms of hydrochloride 2- (R) - (1- (R) - (3,5-bis (trifluoromethyl) -phenyl) -ethoxy) -4- (5- (dimethyl -amino) methyl-1,2,3-triazol-4-yl) methyl-3- (S) - (4-fluorophenyl) morpholine, in terms of thermodynamic stability and suitability for inclusion in pharmaceutical formulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP003740 ECSP003740A (en) | 2000-10-27 | 2000-10-27 | POLYMORPHIC FORM OF A TACHYQUININE RECEPTOR ANTAGONIST |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP003740 ECSP003740A (en) | 2000-10-27 | 2000-10-27 | POLYMORPHIC FORM OF A TACHYQUININE RECEPTOR ANTAGONIST |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003740A true ECSP003740A (en) | 2000-12-19 |
Family
ID=42041316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP003740 ECSP003740A (en) | 2000-10-27 | 2000-10-27 | POLYMORPHIC FORM OF A TACHYQUININE RECEPTOR ANTAGONIST |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP003740A (en) |
-
2000
- 2000-10-27 EC ECSP003740 patent/ECSP003740A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO996549L (en) | Polymorphic form of the tachykinin receptor antagonist 2- (R) - (1- (R) - | |
ZA985765B (en) | Polymorphic form of a tachykinin receptor antagonist. | |
RS50404A (en) | Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist | |
PE20040892A1 (en) | ACETYLCHOLINE MUSCARINE M3 RECEPTOR ANTAGONISTS | |
TW200519084A (en) | Cyclic amine bace-1 inhibitors having a benzamide substituent | |
CR7332A (en) | INHIBITORS OF THE FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE CASCADA DE LA COAGULACION | |
DK1778677T3 (en) | Heterocyclic condensed compounds useful as antidiuretic agents | |
NO20026094L (en) | Condensed azepine derivatives and their use as antidiuretic agents | |
GT200000034A (en) | COMPOUNDS AND PROCEDURES FOR THE TREATMENT OF ASTHMA, ALLERGY AND INFLAMMATORY DISORDERS. | |
NO20062143L (en) | Extended-release venlafaxine tablet formulations | |
AR026288A1 (en) | POLYMORPHIC FORM OF AN TAQUICININE RECEIVER ANTAGONIST | |
ECSP003740A (en) | POLYMORPHIC FORM OF A TACHYQUININE RECEPTOR ANTAGONIST | |
EE200100520A (en) | N- (2-phenyl-4-aminobutyl) -1-naphthamides as neurokinin-1 receptor antagonists | |
ECSP982575A (en) | POLYMORPHIC FORM OF A TACHYQUININE RECEPTOR ANTAGONIST | |
PA8559201A1 (en) | AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO | |
ATE293591T1 (en) | NEW N-(2-PHENYL-3-AMINOPROPYL)NAPHTAMIDE | |
MY126509A (en) | Polymorphic form of a tachykinin receptor antagonist | |
ECSP034549A (en) | CRYSTALLINE FORMS OF 1- (6-CHLORINE-5- (TRIFLUOROMETIL) -2-PIRIDINIL) HYDROCHLORIDE PIPERAZINE | |
TH77074A (en) | Pharmaceutical constituents of tacchinin receptor antagonists | |
UY26971A1 (en) | NEW NEUROQUININE ANTAGONISTS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
AR040908A1 (en) | S - (+) -3- ((1- (2- (2,3-DIHIDRO-1HINDOL3IL) ETIL) 3,6-DIHIDRO- 2H- PIRIDIN-4-IL)) - 6-CHLORINE-1H-INDOL, ADDITION SALTS OF THE SAME ACID AND PHARMACEUTICAL COMPOSITION | |
AR039117A1 (en) | THE USE OF 3- (1- (2- (1-ACETIL-2,3-DIHIDRO-1H-INDOL-3-IL) ETIL) -3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6- CHLORINE-1H-INDOL OR ITS ENANTIOMERS FOR THE TREATMENT OF DISEASES AND DISORDERS THAT RESPONSE TO THE INHIBITION OF THE RECOVERY OF 5-HT (SEROTONIN) | |
TH67344A (en) | New mixtures |